Home › Follicular Lymphoma › Utah › Salt Lake City
Pag-aaral pangklinika para sa Follicular Lymphoma sa Salt Lake City, UT
Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Nagre-recruitPhase 3
- Huntsman Cancer Institute - Oncology Division, Salt Lake City
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- Intermountain Healthcare, Salt Lake City
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Nagre-recruitPhase 3
- Research Site, Salt Lake City
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- Huntsman Cancer Insititute, University of Utah, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Nagre-recruitPhase 2
- University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Nagre-recruitPhase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Nagre-recruitPhase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Salt Lake City
Pag-aaral para sa Follicular Lymphoma sa ibang lungsod
- New York City, NY24 pag-aaral
- Milwaukee, WI19 pag-aaral
- Houston, TX18 pag-aaral
- Nashville, TN18 pag-aaral
- Boston, MA17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Seattle, WA15 pag-aaral
- Durham, NC15 pag-aaral
- Columbus, OH13 pag-aaral
- San Antonio, TX12 pag-aaral
- Philadelphia, PA12 pag-aaral
- Chicago, IL12 pag-aaral
Iba pang pag-aaral sa Salt Lake City
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser sa Suso28 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Colorectal Cancer22 pag-aaral
- Melanoma21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Kanser sa Baga21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Obesity16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.